According to the latest research by InsightAce Analytic, the global global Neurovascular Embolization Devices market is valued at US$ 1.34 billion, and it is expected to grow with a CAGR of 5.79 % during a forecast period of 2022-2030. These coils are prescription equipment implanted into the aneurysm sac by a physician to block blood flow and promote thrombosis. Since coil-treated aneurysms may have residual filling or recur, placing the patient at risk for late hemorrhage, follow-up imaging is done when post-procedure is required. Digital Subtraction Angiography (DSA) was traditionally the method used after coiling to imagine aneurysms. However, since improvements in image clarity and usability of MRA, many health care providers can opt to use MRA instead of DSA, so patients are not vulnerable to an embolic stroke or ionizing radiation hazards.
With the help of embolization coils and liquid embolic systems, healthcare companies in the neurovascular embolization devices (neurology) market have successfully laid a solid foundation for treatment options. However, with some health problems, such as wide-neck bifurcated aneurysms, specific therapeutic methods pose particular difficulties. Manufacturers are introducing monotherapy saccular implants to overcome this challenge. Centered on the same principle, healthcare companies are designing Woven EndoBridge (WEB) aneurysm embolization solutions in the neurovascular embolization devices (neurology) industry that resolve the complications associated with coil-assist devices and surgical clippings.
The neurovascular embolization devices market is a segment based on product type, end-user, and geography. In terms of product type, the global market is segregated into aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils, and intravascular flow disruptors. The embolization coils product segment is expected to dominate the global neurovascular embolization devices (neurology) during the forecast period. The rapid acceptance and growing demand for embolization coils, since they are one of the oldest recognized embolization instruments, and well-trained interventional radiologists in conducting embolization procedures with these instruments since opposed to others, make them essential for specific embolization procedures.
Based on end-user, the global neurovascular embolization devices market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Globally, the increase in the prevalence of stroke is projected to drive the global market for neurovascular embolization devices (neurology) during the forecast period. About 33 million people globally suffer from stroke, according to WHO, last year. In comparison, in low- and middle-income economies, 70 per cent of stroke and 87% of stroke-related injuries and mortalities exist. In addition, stroke incidence rates in low- and middle-income countries have more than doubled in the last four decades. Stroke is the second-largest cause of mortality and the third-largest cause of disability worldwide. The increase in prevalence and burden of stroke will drive the need for surgery, which is expected to accelerate the growth of the global market for neurovascular embolization devices (neurology) in the coming years.
Based on geography, the global neurovascular embolization devices market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, over the forecast period, North America is expected to account for a leading share of the global market for neurovascular embolization devices (neurology), owing to a rise in occurrence levels of neurovascular diseases, especially brain aneurysm, in the United States. According to the Brain Aneurysm Foundation, the brain aneurysm has been unbroken by 1 in 50 people, or 6 million individuals in the U.S. Every year around 30,000 people in the country suffer from rupture of cerebral aneurysm. That, in turn, is expected to drive the country’s demand for neurovascular embolization devices (neurology).
The Asia Pacific demand for neurovascular embolization devices (neurology) is expected to expand at a fast pace in the near future. Given the high prevalence of cerebrovascular disorders, unhealthy lifestyle choices such as smoking, bad diets, and high incidence of diabetes and hypertension, India and China are projected to be attractive markets during the forecast period,
Some of the market players leading the global Neurovascular Embolization Devices market include Acandis GmBH, B. Braun, BALT Extrusion, Emboflu, Stryker, Johnson & Johnson (Cerenovus), KLS Martin, Medtronic Plc, Mizuho Medical, Peter Lazic GmBH, Phenox GmBH, Spartan Micro, Terumo Corporation (MicroVention) among others.
